Home Latest Articles
Latest Articles
  • Jianjun GAO, Siriguleng, Jiqing MENG, Xiaoxia WANG, Li WANG, Xiaobin GUO
    World Clinical Drug. 2022, 43(11): 1393-1398.

    Patients with malignant tumors are at high risk for infection, and antibacterials are crucial means of infection control and prevention. Antibacterials can influence tumor therapy by acting on human intestinal microbial ecosystem. In recent years, correlation between gut microbiota and tumors has become focus of attention. Studies have shown that gut microbiota are closely related to tumor therapy and adverse drug reactions. With the goal of providing insights into clinical tumor therapy and new ideas, this review article describes the effects of antibacterials on tumor immunotherapy, chemotherapy and radiotherapy.

  • Siriguleng, Huanhuan LIU, Yue ZHOU, Wurihan, Wudan, Hongxin YANG
    World Clinical Drug. 2022, 43(11): 1399-1404.

    Bacterial drug resistance is increasing and poses a significant threat to human public health safety. Along with the increasing number of drug-resistant bacteria, it brings great difficulties to clinical treatment, resulting in treatment failure, increased medical costs and mortality, and brings huge health and economic burden to patients. In this article, we collate the literature on the health and economic burden of bacterial resistance at home and abroad in recent years, and describe the current status of research on the burden caused by drug-resistant bacteria, in order to make readers understand the overview of the burden caused by bacterial resistance, and then provide reference for the national policies to curb bacterial drug resistance.

  • Wanmeng ZHANG, Siriguleng, Kexin DU, Lin HU, Yaoyao YANG, Bo ZHENG, Xiaodong GUAN, Haishaerjiang WUSHOUER, Luwen SHI
    World Clinical Drug. 2022, 43(11): 1405-1411.

    Antimicrobial resistance is one of the major threats to public health in the world today. At present, gram-negative bacteria have become the main cause of infection in China, among which the detection rate of carbapenem-resistant Klebsiella pneumoniae has been increasing significantly. As one of the most important antibiotics widely used in the treatment of severe infections caused by gram-negative bacteria, there have been some studies on the correlation between the consumption of carbapenems and the resistance of carbapenem resistant gram-negative bacteria, but correlation between the consumption of original and generic drugs and bacterial resistance is still unknown. Based on the data of drug purchase volume of 869 hospitals in 30 provinces in China and the data of drug resistance rate in China Antimicrobial Resistance Surveillance System from 2016 to 2020, this paper analyzed the quarterly usage change and compound annual growth rate of carbapenems, the changing trend of drug resistance rate of gram-negative bacteria, as well as the correlation between the generic/original drug consumption ratio and drug resistance of gram-negative bacteria. Recent researches at home and abroad were also discussed, in order to provide empirical evidence for the formulation of relevant drug policy in China, and to promote the rational use of antibiotics and curb bacterial resistance.

  • Mingcui LIU, Jiangyue TANG, Pingping GOU, Aijun HAN, Rong REN, Hua YI
    World Clinical Drug. 2022, 43(11): 1412-1420.
    Objective

    To investigate the effect and mechanism of lncRNA DLEU1 on paclitaxel resistant ovarian cancer cells.

    Methods

    The ovarian cancer paclitaxel resistant SKOV3/TAX cells were transfected with small interfering RNA, siRNA (siRNA), overexpression plasmid and negative control (NC) sequence respectively, and were set as DLEU1-siR group, DLEU1 (+) group and NC group, and the non-transfected cells were set as control group. qRT-PCR was used to verify lncRNA DLEU1 transfection. MTS method was used to detect the effect of lncRNA DLEU1 on the paclitaxel resistance of SKOV3/TAX cells. Flow cytometry and Traswell assay were used to detect the effects of lncRNA DLEU1 on apoptosis and invasion of SKOV3/TAX cells. The targeting relationship between lncRNA DLEU1 and microRNA (miR)-149 was analyzed by dual luciferase reporter, and the effect of lncRNA DLEU1 on the expression of miR-149 gene and PI3K/AKT pathway protein were confirmed by qRT-PCR and western blotting.

    Results

    Compared with the control group and NC group, the inhibition rate of paclitaxel in SKOV3/TAX cells in the DLEU1-siR group was significantly increased, and the inhibition rate in the DLEU1 (+) group decreased significantly, and the difference was statistically significant (P<0.05). The apoptosis rate of DLEU1-siR group was 16.8%, which was significantly higher than that of the control group (5.9%) and NC group (6.9%); The apoptosis rate of 3.4% in the DLEU1 (+) group, which was significantly lower than that of the control group and the NC group, and the difference was statistically significant (P<0.05). The number of invasion and perforation cells in the DLEU1-siR group was (85±8), which was significantly lower than that of the control group (135±16) and the NC group (129±12); The number of invasion and perforation cell in the DLEU1 (+) group was (189±15), which was significantly higher than that of the control group and the NC group, and the difference was statistically significant (P<0.05). There are targeted binding sites between lncRNA DLEU1 and miR-149, and the two are negatively regulated. Compared with the control group and NC group, the expression of phospho-PI3K and phospho-AKT proteins in the DLEU1-siR group decreased significantly, while the expression of the two proteins in the DLEU1 (+) group increased significantly, and the difference was statistically significant (P<0.05).

    Conclusion

    Overexpression of lncRNA DLEU1 can enhance the resistance of SKOV3/TAX cells to paclitaxel, and its mechanism of action may be related to the regulation of PI3K/AKT pathway by lncRNA DLEU1 targeting miR-149.

  • Na LI, Hongli ZHANG, Siyun TANG, Xiaohua LI
    World Clinical Drug. 2022, 43(11): 1421-1425.
    Objective

    To explore the regularity of prescription and taste tropism in treating diabetes in the database of traditional Chinese medicine think tank (ancient books).

    Methods

    With the keywords of "eliminating thirst" "three elimination" "eliminating kidney" "li elimination" "spleen dan" and "eliminating dan", we searched the relevant ancient books in the database of traditional Chinese medicine think tank (ancient books), entered the data with excel, and used frequency and cluster analysis to explore the characteristics of prescriptions and medication rules in ancient books for treating diabetes.

    Results

    Eleven ancient medical books from the Jin dynasty to the modern times were retrieved, 61 prescriptions were obtained after the duplication was removed, and the high-frequency prescriptions included Ginseng Baihu decoction, Baizhu powder and Tiaowei Chengqi decoction. There are 42 high-frequency Chinese medicines, including ginseng, licorice, rehmannia glutinosa and ophiopogon japonicus, among which cold (39.53%) and sweet (41.54%) are the main. Kidney (21.92%) and lung (19.21%) were the main channels.

    Conclusion

    Mining the rule of drug use in ancient books through the database can guide clinical application and experimental research, and make the classic prescriptions bloom with new vitality.

  • Yingchuan YUAN, Ying HUANG, Aifang CHEN
    World Clinical Drug. 2022, 43(11): 1426-1432.
    Objective

    To compare and investigate the effects of two doses of dexmedetomidine (DEX) on oxidative stress indexes, waking agitation and brain protection in children with cerebral palsy undergoing common carotid artery exfoliation.

    Methods

    A total of 90 children with cerebral palsy who received common carotid artery exfoliation were randomly divided into group D1 (inducible intravenous injection of DEX 0.4 μg/kg), group D2 (inducible intravenous injection of DEX 0.8 μg/kg) and group C (inducible intravenous injection of normal saline), with 30 cases in each group. The wake time, extubation time, heart rate (HR) and mean arterial pressure (MAP)[at the time of entry (T0), at the time of intubation (T1), at the beginning of surgery (T2), at the time of intraoperative peeling of the carotid artery (T3), at the end of surgery (T4), at the time of extubation (T5)], oxygen saturation of blood (SO2), agitation during the recovery period [immediately upon arrival in the recovery room (Tp0), 5 minutes (Tp5), 10 minutes (Tp10), 25 minutes (Tp25), 40 minutes (Tp40)] and brain protective evaluation indexes of the three groups were compared.

    Results

    The wake time and extubation time of group D2 were longer than those of group D1 and C (P<0.05). In T1-T5, HR and MAP of group D1 and D2 were lower than those of group C (P<0.05). There was no significant difference in SO2 among the three groups (P>0.05). The plasma epinephrine and cortisol levels among the 3 groups at T4 were higher than those at T0 (P<0.05), and those in group D1 and D2 were lower than those in group C (P<0.05). The incidence of restfulness in Tp0-Tp40, group D1 and D2 were lower than that in group C (P<0.05). The levels of serum central nerve specific protein and neuron-specific enolase among the 3 groups were higher than those in T0 at 6 h and 12 h after surgery (P<0.05), and those in group D1 and D2 were lower than those in group C (P<0.05).

    Conclusion

    Common carotid artery extirpation and intravenous administration of 0.4 μg/kg and 0.8 μg/kg DEX before induction can significantly reduce the incidence of agitation during recovery, stabilize physiological indexes such as HR, MAP and SO2, and play a protective role in brain tissue. The dosage of 0.4 μg/kg was significantly better than that of 0.8 μg/kg in shortening recovery time and extubation time.

  • Yuxia MEI, Yun GAI, Lina CHEN, Siyu CHEN, Donghai YU, Cheng ZHUANG
    World Clinical Drug. 2022, 43(11): 1433-1439.
    Objective

    To observe the curative effects of recombinant human growth hormone (r-hGH) in the treatment of short stature and the effects of massage therapy on adipokines.

    Methods

    A total of 96 children with idiopathic short stature admitted to the department of pediatrics, seventh people's hospital affiliated to Shanghai university of traditional Chinese medicine from January 2018 to December 2019 were selected and divided into observation group and control group according to random number method, with 48 cases in each group. The control group was given r-hGH, and the observation group was combined with promoting massage on the basis of the control group. The clinical efficacy, height standard deviation score (HtSDS), growth velocity (GV), difference value of prediction of adult height (PAH), fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model insulin resistance index (HOMA-IR), serum osteocalcin (OCN), 25 hydroxyvitamin D[25(OH)D], insulin-like growth factor (IGF)-1, leptin, adiponectin and endolipin levels.

    Results

    The total effective rate of the observation group was higher than that of the control group (85.4% vs 62.50%, P<0.05). After treatment, the levels of serum leptin and endolipin in both groups were significantly decreased compared with those before treatment (P<0.01), and the levels in the observation group were significantly decreased compared with the control group (P<0.01). HtSDS, GV, difference value of PAH, FBG, FINS, HOMA-IR, OCN, 25(OH)D, IGF-1 and adiponectin levels in two groups were significantly increased compared with those before treatment (P<0.01). The increased levels of HtSDS, GV, PAH difference, OCN, 25(OH)D, IGF-1 and adiponectin in the observation group were more significant than those in the control group (P<0.01), and the increased levels of FBG, FINS and HOMA-IR in the control group were more significant than those in the observation group (P<0.01).

    Conclusion

    The combination of r-hGH and massage can significantly improve the growth rate, reduce IR and regulate bone metabolism, which may be related to the alleviation of adipokine disorders.

  • Wenjuan ZHAO, Shiguo XIA
    World Clinical Drug. 2022, 43(11): 1440-1445.
    Objective

    To explore the effects of paricalcitol combined with valsartan on levels of renal fibrosis indexes, high mobility group protein (HMG) B1 and nuclear transcription factor (NF)-κB in patients with diabetic nephropathy (DN).

    Methods

    A total of 120 patients with DN admitted to the outpatient of Shanghai Jiao Tong university affiliated sixth people's hospital south campus were enrolled from May 2020 to May 2021. According to random number table method, they were divided into paricalcitol group (paricalcitol), valsartan group (valsartan) and combination group (paricalcitol combined with valsartan), 40 cases in each group. After 1 month of continuous treatment, clinical curative effect and levels of renal function indexes [β2 microglobulin (β2M), creatinine (Cr)], renal fibrosis indexes [cystatin (Cys) C, tissue inhibitor of metalloproteinase (TIMP)-1], HMGB1 and NF-κB in different groups were compared. The occurrence of adverse reactions during treatment was recorded in each group.

    Results

    The total effective rate of combination group was higher than that in paricalcitol group (87.50% vs 65.00%, P<0.05). After treatment, the levels of β2M, Cr, CysC, TIMP-1, HMGB1 and NF-κB in combination group were lower than those in valsartan group and paricalcitol group (P<0.05).

    Conclusion

    Compared with paricalcitol monotherapy, paricalcitol combined with valsartan has better effect of on DN, which can effectively improve renal function, delay renal fibrosis and better regulate the levels of HMGB1 and NF-κB.

  • Huicheng ZHAO, Yanmei ZHAO, Rongmei JIA, Hui LI, Rong ZHU
    World Clinical Drug. 2022, 43(11): 1446-1450.
    Objective

    To investigate the clinical effects of Siwei Anshenyin on improving micro-inflammatory level in non-dialysis patients with chronic renal failure (CRF).

    Methods

    A total of 146 non-dialysis patients with CRF who visited the outpatient department of nephrology, the fifth people's hospital of Hengshui from September 2020 to March 2021 were selected and randomly divided into control group and observation group, with 73 patients in each group. The control group was treated with CRF, and the observation group was treated with Siwei Anshenyin based on the control group. The efficacy evaluation of traditional Chinese medicine (TCM) syndromes, renal function, electrolytes and micro-inflammation indexes were compared between the two groups.

    Results

    The total effective rate of TCM syndromes in the observation group was higher than that in the control group (61.64% vs 45.21%), the difference was statistically significant (P<0.05). After treatment, blood urea nitrogen (BUN), serum creatinine (Scr), high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, tumor necrosis factor (TNF)-α and monocyte chemotactic protein (MCP)-1 decreased compared with that before treatment. The differences were statistically significant (P<0.05). BUN, Scr, hsCRP, IL-6, TNF-α and MCP-1 in observation group were lower than those in control group, and the differences were statistically significant (P<0.05).

    Conclusion

    Siwei Anshenyin can effectively reduce the micro-inflammatory level of non-dialysis patients with CRF, improve TCM symptoms and renal function, and delay the progression of the disease.

  • Xuebin WANG, Wei SI, Jingwen LI, Jianjun ZHANG, Feng WANG
    World Clinical Drug. 2022, 43(11): 1451-1456.
    Objective

    To investigate the effect of Nicorandil on percutaneous coronary intervention (PCI) in the treatment of acute coronary syndrome (ACS).

    Methods

    A total of 124 patients with ACS who were to be treated by PCI were randomly divided into control group (n=61) and intervention group (n=63). The control group was treated with bivalirudin, and the intervention group was treated with nicorandil on the basis of the control group. Endothelial function indexes, blood flow classification of myocardial infarction thrombolysis (TIMI), in-stent restenosis and major adverse cardiac events (MACE) were compared between the two groups before and after treatment, and serum cardiac troponinⅠ(cTnⅠ), creatine kinase isoenzymes (CK-MB), interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α horizontal were detected.

    Results

    After treatment, brachial artery blood flow mediated vasodilation (FMD), the levels of nitric oxide (NO), cTnⅠ, CK-MB, IL-6, IL-10 and TNF-α in the two groups were higher than before treatment, the levels of endothelin-1 (ET-1) were lower than before treatment (P<0.05), and the levels of FMD, NO, IL-10 in the intervention group were higher than those of control group, the levels of ET-1, cTnⅠ, CK-MB, IL-6 and TNF-α were lower than those of control group (P<0.05). After treatment, TIMI blood flow grading in the intervention group was significantly different from that of control group (P<0.05). The in-stent restenosis rate of 1.59% and MACE incidence rate of 9.52% in the intervention group were lower than those of 19.67% and 63.93% in the control group (P<0.05).

    Conclusion

    Nicorandil can improve endothelial function and TIMI blood flow grading after PCI in ACS patients, relieve myocardial injury and inflammatory reaction, and effectively reduce in-stent restenosis and MACE.

News